Clinical Trial Update: Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Aconite Pain Oil to prevent chemotherapy-induced polyneuropathy and improve symptoms and quality of life in cancer patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Polyneuropathy

Drugs mentioned

• Aconite Pain Oil

Snippet

Sponsor: WALA Heilmittel GmbH | Conditions: Chemotherapy-induced Polyneuropathy | Phase 3 | Status: RECRUITING